The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy

被引:28
作者
Vicini, Frank A.
Antonucci, J. Vito
Goldstein, Neal
Wallace, Michelle
Kestin, Larry
Krauss, Daniel
Kunzmann, Jonathan
Gilbert, Samuel
Schell, Scott
机构
[1] William Beaumont Hosp, Dept Radiat Oncol, Beaumont Canc Inst, Royal Oak, MI 48073 USA
[2] William Beaumont Hosp, Dept Pathol, Royal Oak, MI 48073 USA
[3] William Beaumont Hosp, Dept Surg, Royal Oak, MI 48073 USA
关键词
breast-conserving therapy; local recurrence; loss of heterozygosity; radiation therapy; lumpectomy;
D O I
10.1002/cncr.22529
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. Results from numerous trials have indicated that breast-conserving therapy (BCT) produces outcomes equivalent to those produced by mastectomy in terms of both locoregional control and survival. However, conservative treatment has resulted in the dilemma of how best to address recurrences when they appear in a breast treated previously with radiation therapy. Attempts have been made to characterize ipsilateral breast tumor recurrences (IBTRs) as either true recurrences of the treated malignancy or new primary carcinomas, because cancers that represent new primary tumors may be associated with a more favorable prognosis compared with cancers that represent true recurrences. METHODS. The authors studied the clonality of IBTRs relative to the initial invasive carcinomas by using a polymerase chain reaction loss-of-heterozygosity molecular comparison assay in 29 patients who received breast-conserving therapy (BCT). RESULTS. Twenty-two IBTRs (76%) were related clonally to the initial carcinoma, and 7 IBTRs (24%) were clonally different. Clonally related IBTRs were more frequently higher grade (72.2% vs 14.3%; P = .009) and developed sooner after initial treatment (mean time to IBTR, 4.04 years in clonally related IBTRs vs 9.25 years in clonally different IBTRs; P = .002). Six patients subsequently developed distant metastases, and 5 of those patients (83.3%) had clonally related IBTRs. Clinical IBTR classification and molecular clonality assay results differed in 30% of all patients. The proportion of IBTRs that were related clonally at 5 years, 10 years, and 15 years after BCT were 93%, 67%, and 33%, respectively CONCLUSIONS. Clinical classifications of IBTRs were unreliable methods for determining clonality in many patients. Molecular clonality assays provided a reliable means of identifying patients who may benefit from aggressive systemic therapy at the time of IBTR and also provided a more accurate assessment of the efficacy of various forms of local therapy.
引用
收藏
页码:1264 / 1272
页数:9
相关论文
共 50 条
[41]   Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer [J].
Touboul, E ;
Buffat, L ;
Belkacémi, Y ;
Lefranc, JP ;
Uzan, S ;
Lhuillier, P ;
Faivre, C ;
Huart, J ;
Lotz, JP ;
Antoine, M ;
Pène, F ;
Blondon, J ;
Izrael, V ;
Laugier, A ;
Schlienger, M ;
Housset, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (01) :25-38
[42]   Obtaining Adequate Surgical Margins in Breast-Conserving Therapy for Patients with Early-Stage Breast Cancer: Current Modalities and Future Directions [J].
Pleijhuis, Rick G. ;
Graafland, Maurits ;
de Vries, Jakob ;
Bart, Joost ;
de Jong, Johannes S. ;
van Dam, Gooitzen M. .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (10) :2717-2730
[43]   Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy [J].
Singletary, SE .
AMERICAN JOURNAL OF SURGERY, 2002, 184 (05) :383-393
[44]   Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy - Comparison with clinical and biologic factors [J].
Goldstein, NS ;
Vicini, FA ;
Hunter, S ;
Odish, E ;
Forbes, S ;
Kraus, D ;
Kestin, LL .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 123 (05) :679-689
[45]   Impact of the mode of detection on outcome in breast cancer patients treated with breast-conserving therapy [J].
Kini, VR ;
Vicini, FA ;
Victor, SJ ;
Dmuchowski, CF ;
Rebner, M ;
Martinez, AA .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (05) :429-435
[46]   The impact of age on the risk of ipsilateral breast tumor recurrence after breast-conserving therapy in breast cancer patients with a > 5 mm margin treated without boost irradiation [J].
Yuka Ono ;
Michio Yoshimura ;
Kimiko Hirata ;
Chikako Yamauchi ;
Masakazu Toi ;
Eiji Suzuki ;
Masahiro Takada ;
Masahiro Hiraoka ;
Takashi Mizowaki .
Radiation Oncology, 14
[47]   Concurrent Lobular Neoplasia Increases the Risk of Ipsilateral Breast Cancer Recurrence in Patients With Ductal Carcinoma in Situ Treated With Breast-conserving Therapy [J].
Rudloff, Udo ;
Brogi, Edi ;
Brockway, Julia P. ;
Goldberg, Jessica I. ;
Cranor, Milicent ;
Wynveen, Christine A. ;
Nehhozina, Tatjana ;
Reiner, Anne S. ;
Patil, Sujata ;
Van Zee, Kimberly J. .
CANCER, 2009, 115 (06) :1203-1214
[48]   Dosimetric Comparison of Sequential Versus Simultaneous-integrated Boost in Early-stage Breast Cancer Patients Treated With Breast-conserving Surgery [J].
Onal, Cem ;
Efe, Esma ;
Guler, Ozan C. ;
Yildirim, Berna A. .
IN VIVO, 2019, 33 (06) :2181-2189
[49]   Breast-conserving therapy is associated with better survival than mastectomy in Early-stage breast cancer: A propensity score analysis [J].
Ji, Jiali ;
Yuan, Shushu ;
He, Jiawei ;
Liu, Hong ;
Yang, Lei ;
He, Xuexin .
CANCER MEDICINE, 2022, 11 (07) :1646-1658
[50]   The Association of Surgical Margins and Local Recurrence in Women with Early-Stage Invasive Breast Cancer Treated with Breast-Conserving Therapy: A Meta-Analysis [J].
Houssami, Nehmat ;
Macaskill, Petra ;
Marinovich, M. Luke ;
Morrow, Monica .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (03) :717-730